Diet and risk of glioma: combined analysis of 3 large prospective studies in the UK and USA.


Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
11 07 2019
Historique:
pubmed: 29 1 2019
medline: 23 7 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Available evidence on diet and glioma risk comes mainly from studies with retrospective collection of dietary data. To minimize possible differential dietary recall between those with and without glioma, we present findings from 3 large prospective studies. Participants included 692 176 from the UK Million Women Study, 470 780 from the US National Institutes of Health-AARP study, and 99 148 from the US Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cox regression yielded study-specific adjusted relative risks for glioma in relation to 15 food groups, 14 nutrients, and 3 dietary patterns, which were combined, weighted by inverse variances of the relative risks. Separate analyses by <5 and ≥5 years follow-up assessed potential biases related to changes of diet before glioma diagnosis. The 1 262 104 participants (mean age, 60.6 y [SD 5.5] at baseline) were followed for 15.4 million person-years (mean 12.2 y/participant), during which 2313 incident gliomas occurred, at mean age 68.2 (SD 6.4). Overall, there was weak evidence for increased glioma risks associated with increasing intakes of total fruit, citrus fruit, and fiber and healthy dietary patterns, but these associations were generally null after excluding the first 5 years of follow-up. There was little evidence for heterogeneity of results by study or by sex. The largest prospective evidence to date suggests little, if any, association between major food groups, nutrients, or common healthy dietary patterns and glioma incidence. With the statistical power of this study and the comprehensive nature of the investigation here, it seems unlikely we have overlooked major effects of diet on risk of glioma that would be of public health concern.

Sections du résumé

BACKGROUND
Available evidence on diet and glioma risk comes mainly from studies with retrospective collection of dietary data. To minimize possible differential dietary recall between those with and without glioma, we present findings from 3 large prospective studies.
METHODS
Participants included 692 176 from the UK Million Women Study, 470 780 from the US National Institutes of Health-AARP study, and 99 148 from the US Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cox regression yielded study-specific adjusted relative risks for glioma in relation to 15 food groups, 14 nutrients, and 3 dietary patterns, which were combined, weighted by inverse variances of the relative risks. Separate analyses by <5 and ≥5 years follow-up assessed potential biases related to changes of diet before glioma diagnosis.
RESULTS
The 1 262 104 participants (mean age, 60.6 y [SD 5.5] at baseline) were followed for 15.4 million person-years (mean 12.2 y/participant), during which 2313 incident gliomas occurred, at mean age 68.2 (SD 6.4). Overall, there was weak evidence for increased glioma risks associated with increasing intakes of total fruit, citrus fruit, and fiber and healthy dietary patterns, but these associations were generally null after excluding the first 5 years of follow-up. There was little evidence for heterogeneity of results by study or by sex.
CONCLUSIONS
The largest prospective evidence to date suggests little, if any, association between major food groups, nutrients, or common healthy dietary patterns and glioma incidence. With the statistical power of this study and the comprehensive nature of the investigation here, it seems unlikely we have overlooked major effects of diet on risk of glioma that would be of public health concern.

Identifiants

pubmed: 30690490
pii: 5299220
doi: 10.1093/neuonc/noz013
pmc: PMC6620629
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

944-952

Subventions

Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology.

Références

Neuro Oncol. 2011 Feb;13(2):242-50
pubmed: 21149253
Int J Cancer. 2016 Dec 15;139(12):2714-2721
pubmed: 27560973
Cancer Causes Control. 2002 Sep;13(7):647-55
pubmed: 12296512
J Epidemiol Community Health. 1996 Aug;50(4):442-6
pubmed: 8882229
Cancer Prev Res (Phila). 2011 Nov;4(11):1903-11
pubmed: 21803982
Ann Epidemiol. 2009 Mar;19(3):161-71
pubmed: 19216998
Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S
pubmed: 11189684
J Agric Saf Health. 2006 Nov;12(4):255-74
pubmed: 17131948
Am J Epidemiol. 1986 Aug;124(2):334-7
pubmed: 3728449
Eur J Nutr. 2019 Feb;58(1):103-111
pubmed: 29124385
Am J Clin Nutr. 2009 Sep;90(3):570-7
pubmed: 19587083
Int J Cancer. 2011 Apr 15;128(8):1929-34
pubmed: 21344375
Am J Epidemiol. 1997 Nov 15;146(10):832-41
pubmed: 9384204
Int J Epidemiol. 2019 Feb 1;48(1):28-29e
pubmed: 29873753
Am J Epidemiol. 2001 Dec 15;154(12):1119-25
pubmed: 11744517
J Neurooncol. 2012 Sep;109(2):315-21
pubmed: 22588335
Arch Intern Med. 2008 Apr 14;168(7):713-20
pubmed: 18413553
Int J Epidemiol. 2003 Dec;32(6):1054-62
pubmed: 14681273
Public Health Nutr. 2011 Nov;14(11):1998-2005
pubmed: 21729481
Br J Cancer. 2008 Jul 8;99(1):185-90
pubmed: 18560401
J Nutr. 2012 Jun;142(6):1009-18
pubmed: 22513989
Int J Cancer. 1993 Feb 20;53(4):561-5
pubmed: 8436429
PLoS Med. 2007 Dec;4(12):e325
pubmed: 18076279
Cancer Causes Control. 1997 Jan;8(1):5-12
pubmed: 9051317
Public Health Nutr. 2008 Feb;11(2):183-95
pubmed: 17610761
J Neurooncol. 2004 May;68(1):57-69
pubmed: 15174522
Br J Cancer. 2014 Jan 7;110(1):242-8
pubmed: 24335921
Lancet. 1990 Mar 31;335(8692):765-74
pubmed: 1969518
Am J Clin Nutr. 2013 Jan;97(1):127-34
pubmed: 23193004
Int J Cancer. 1994 Nov 1;59(3):357-62
pubmed: 7927941
Control Clin Trials. 2000 Dec;21(6 Suppl):356S-378S
pubmed: 11189688
BMC Cancer. 2006 Jun 03;6:148
pubmed: 16749939
J Natl Cancer Inst. 1987 Apr;78(4):601-9
pubmed: 3104645
Public Health Nutr. 2005 Apr;8(2):201-13
pubmed: 15877913
Neuroepidemiology. 1989;8(5):266-75
pubmed: 2812186
Br J Nutr. 2016 Mar 28;115(6):1108-16
pubmed: 26856761
Br J Cancer. 2015 Sep 1;113(5):809-16
pubmed: 26291054
Cancer Causes Control. 2012 May;23(5):757-68
pubmed: 22457000
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1709-22
pubmed: 20570910
Am J Clin Nutr. 2007 Mar;85(3):877-86
pubmed: 17344512
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Am J Clin Nutr. 2010 Nov;92(5):1145-50
pubmed: 20844074
Eur J Cancer Prev. 2018 Jul;27(4):379-383
pubmed: 27845960
Am J Clin Nutr. 2010 Dec;92(6):1429-35
pubmed: 21097651
J Neurooncol. 1990 Feb;8(1):55-60
pubmed: 2319291
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):39-47
pubmed: 20056621

Auteurs

Ai Seon Kuan (AS)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Jane Green (J)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Cari M Kitahara (CM)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Amy Berrington De González (A)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Tim Key (T)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Gillian K Reeves (G)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Sarah Floud (S)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Angela Balkwill (A)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Kathryn Bradbury (K)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Linda M Liao (LM)

Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Neal D Freedman (ND)

Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Valerie Beral (V)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Siân Sweetland (S)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH